MELINTA THERAPEUTICS, INC. /NEW/ Proceeds from Notes Payable
MELINTA THERAPEUTICS, INC. /NEW/ reported Proceeds from Notes Payable of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2019-11-12
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for the quarter ending 2019-09-30 was $0.00.
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for the quarter ending 2019-06-30 was $0.00.
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for the quarter ending 2018-12-31 was $0.00.
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for fiscal 2018 was $111.42M, a 186.84% increase from fiscal 2017.
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for fiscal 2017 was $38.84M, a 11.94% decline from fiscal 2016.
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for fiscal 2016 was $44.11M, a 341.11% increase from fiscal 2015.
- MELINTA THERAPEUTICS, INC. /NEW/ proceeds from notes payable for fiscal 2015 was $10.00M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 3 month as first filed | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 6 month as first filed | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $0.00 derived: sum of 3 quarters · filed 2019-08-09 | $0.00 derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-05-10 | $0.00 derived: sum of 3 quarters · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 derived: sum of 3 quarters · filed 2019-11-12 | $111.42M 10-K · filed 2019-03-14 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $111.42M 10-Q · filed 2019-11-12 | $110.27M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $111.42M 10-Q · filed 2019-08-09 | $104.97M 10-Q · filed 2018-08-09 | $110.27M derived: sum of 3 quarters · filed 2019-08-09 | $120.27M derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | $111.42M 10-Q · filed 2019-05-10 | $104.97M 10-Q · filed 2018-05-10 | $110.27M derived: sum of 2 quarters · filed 2019-05-10 | $120.27M derived: sum of 3 quarters · filed 2019-05-10 | $142.25M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $8.84M derived: sum of 2 quarters · filed 2019-03-14 | $30.83M derived: sum of 3 quarters · filed 2019-03-14 | $38.84M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $31.99M derived: sum of 2 quarters · filed 2018-11-07 | $40.00M 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $21.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $30.00M 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | $8.01M 10-Q · filed 2018-05-10 | |||||
| 2016-12-31 | $44.11M 10-K · filed 2019-03-14 | |||||
| 2015-12-31 | $10.00M 10-K · filed 2018-03-16 |